Millet Products Study - Investigation of Glycemic Index and Satiety

Inclusion Criteria: * Men, age 19-40, non-smoking * Normal fasting plasma glucose (\<5.6 mmol/L but not below 3.6 mmol/L) * Normal glucose tolerance (evaluated by a 75 g oral glucose test, i.e. \<7.8 mmol/L but not below 3.6 mmol/L) * BMI ranging from 18.5 to 29.9 kg/m2 Exclusion Criteria: * Insulin resistance (IR) will be calculated from fasting glucose and insulin values using the Homeostasis Assessment Model 2 (HOMA2). A HOMA2-IR value of greater than 1.0 will be considered indicative of insulin resistance (Levy J.C. et al. 1998). * Regular consumption of millet as defined by questionnaire at screening defined as more than 1x per week * Smoking or use of recreational drugs * Heavy alcohol use (defined as typically \>14 drinks per week or \>4 drinks on one occasion) * Very low fibre consumption as assessed by 24 hour food diary and self-reported fruit/vegetable/whole grain servings. * Restrained eater as defined by the questionnaire at screening (Three Factor Eating Questionnaire, Stunkard et al.,1985) * Food neophobic defined by Food Neophobia Scale questionnaire * Unusual sleep patterns or irregular breakfast consumption * Recent (i.e. \>4 kg in previous 3 months) or intended weight loss or gain * Food allergies or any life-threatening allergy (food or otherwise) * Inflammatory bowel disease or other gastrointestinal disorders * Use of drugs which influence carbohydrate metabolism * Training or elite athletes * Inability to adhere to Study Protocols